CLAUDIA RAMOS-OTERO: Open Payments
NPI 1487919635 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,853 in 77 payments from 20 companies in 2025. Trend: 2023 $389 · 2024 $1,333 · 2025 $1,853
Food & beverage: $1,853
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $437 |
| Amgen Inc. | 18 | $270 |
| AstraZeneca Pharmaceuticals LP | 9 | $258 |
| Boston Scientific Corporation | 1 | $142 |
| ABBVIE INC. | 6 | $106 |
| E.R. Squibb & Sons, L.L.C. | 1 | $86 |
| Exact Sciences Corporation | 4 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $73 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $61 |
| Astellas Pharma US Inc | 3 | $58 |
Products named: Ozempic, AIRSUPRA, OTEZLA, AVVIGO Guidance System, Wegovy, EVENITY, OPDIVO, FARXIGA.
Industry payments across TX — which companies pay providers there.
